Horizon Pharma plc to Present at Three Conferences in November
(firmenpresse) - DUBLIN, IRELAND -- (Marketwired) -- 11/04/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will be presenting at the following conferences in November:
Presentation Date: November 18, 2015
Presentation Time: 10:15 a.m. EST
Location: New York
Presentation Date: November 19, 2015
Presentation Time: 5 a.m. EST/10 a.m. GMT
Location: London
Presentation Date: November 19, 2015
Presentation Time: 9:20 a.m. EST
Location: New York
The presentations will be webcast live and may be accessed by visiting Horizon's website at . A replay of the webcast will be available following each of the events.
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit . Follow on Twitter or view careers on our page.
John Thomas
Executive Vice President, Corporate Strategy and Investor Relations
Tina Ventura
Vice President, Investor Relations
Geoff Curtis
Group Vice President, Corporate Communications
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.11.2015 - 12:00 Uhr
Sprache: Deutsch
News-ID 431818
Anzahl Zeichen: 0
contact information:
Town:
DUBLIN, IRELAND
Kategorie:
Diese Pressemitteilung wurde bisher 159 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma plc to Present at Three Conferences in November"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
